The decision to create Symbiosis in 2011 was driven by the need to address specific gaps highlighted in the sterile drug product manufacturing marketplace. Our aim was to accelerate our clients’ drug development timelines by offering rapid access to sterile fill-finish manufacturing slots and product release services, and this aim has been maintained throughout Symbiosis’ history.
To make this a reality, a team of experts was assembled that understood what a modern, flexible, small-scale GMP aseptic filling facility needed to encompass. Since then, our purpose remains unwavering but our reputation has grown based on manufacturing expertise and operational flexibility, which allows us to tailor process solutions to meet the requirements of your project.
As the demand for biological products and more agile clinical manufacturing grows, we are well-placed to assist clients in developing new drug products.
We are always striving to deliver service excellence and build mutually beneficial, long-term relationships with you based on agreed goals and shared objectives. Our goal to ensure the success of those relationships is to exceed your expectation, first time, every time.
By definition, symbiotic relationships go beyond the individual agenda. That philosophy led us to call the company ’Symbiosis’.
MHRA GMP inspection for commercial manufacturing
Symbiosis Pharmaceutical Services established
MHRA IMP pre-approval